OPHIDIAN PHARMACEUTICALS INC
10-K, EX-27.0, 2000-12-29
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: OPHIDIAN PHARMACEUTICALS INC, 10-K, 2000-12-29
Next: FANTASTICON INC, 10KSB, 2000-12-29



<TABLE> <S> <C>

<ARTICLE>  5


   <S>                                <C>               <C>
<PERIOD-TYPE>                       12-MOS            12-MOS
<FISCAL-YEAR-END>              SEP-30-2000       SEP-30-1999
<PERIOD-END>                   SEP-30-2000       SEP-30-1999
<CASH>                              534097           3416490
<SECURITIES>                             0                 0
<RECEIVABLES>                            0              4112
<ALLOWANCES>                             0                 0
<INVENTORY>                              0                 0
<CURRENT-ASSETS>                    543102           3489405
<PP&E>                             2641250           2050115
<DEPRECIATION>                           0            860732
<TOTAL-ASSETS>                     4163102           6822126
<CURRENT-LIABILITIES>               589452            271495
<BONDS>                                  0                 0
                    0                 0
                              0                 0
<COMMON>                              2896              2888
<OTHER-SE>                         1925256           6183746
<TOTAL-LIABILITY-AND-EQUITY>       4524608           6822126
<SALES>                                  0                 0
<TOTAL-REVENUES>                   1668534             26965
<CGS>                                    0                 0
<TOTAL-COSTS>                         8341                 0
<OTHER-EXPENSES>                   5698237           5188027
<LOSS-PROVISION>                         0                 0
<INTEREST-EXPENSE>                  285714              1862
<INCOME-PRETAX>                  (4274387)         (4860079)
<INCOME-TAX>                             0                 0
<INCOME-CONTINUING>                      0                 0
<DISCONTINUED>                           0                 0
<EXTRAORDINARY>                          0                 0
<CHANGES>                                0                 0
<NET-INCOME>                     (4274387)         (4860079)
<EPS-BASIC>                         (3.69)            (4.21)
<EPS-DILUTED>                       (3.69)            (4.21)




</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission